Simulations Plus expands FDA partnership with ADMET predictor software deal
- Simulations Plus (SLP) Thursday said that the U.S. Food and Drug Administration’s Cosmetics Regulatory Science Branch has licensed ADMET Predictor to support its computational research for modern cosmetic safety assessment.
- The contract expands the use of Simulations Plus technology within the FDA, underscoring the
KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.